Arch Therapeutics Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.04 |
Market Cap |
$51.48 M |
Shares Outstanding |
173.58 M |
Public Float |
130.96 M |
Address |
235 Walnut Street Framingham Massachusetts 01702 United States |
Employees | - |
Website | http://www.archtherapeutics.com |
Updated | 07/08/2019 |
Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development of novel approach to stop bleeding, control leaking, and manage wounds during surgery, trauma, and interventional care. Its products candidates include AC5 Devices. The company was founded by Rutledge Ellis-Behnke and Terrence W. |